metadata toggle
Uses
For the active immunisation of horses aged 5 months of age or older against Equine Influenza of H7N7 and H3N8 types (European or American strains, including Florida sublineage Clade 1 and Clade 2 isolates) to reduce the clinical signs and virus excretion after infection, and against tetanus to prevent mortality.
Equip FT stimulates active immunity against equine influenza virus and tetanus by eliciting both a cell mediated immune response and a humoral response.
Onset of immunity is within 2 weeks of completion of the primary course, with duration of immunity of at least 15 months for the influenza and 36 months for the tetanus.